LE, M., Y, W., A, C., E, S., TP, W., SP, H., . . . A, H. (2025). Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility. JAMA oncology, 11(12), 1540. https://doi.org/10.1001/jamaoncol.2025.3869
Chicago Style (17th ed.) CitationLE, Merz, Wang Y, Cronin A, Sharon E, Walsh TP, Hibbs SP, Lathan CS, and Hantel A. "Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility." JAMA Oncology 11, no. 12 (2025): 1540. https://doi.org/10.1001/jamaoncol.2025.3869.
MLA (9th ed.) CitationLE, Merz, et al. "Duffy Null-Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility." JAMA Oncology, vol. 11, no. 12, 2025, p. 1540, https://doi.org/10.1001/jamaoncol.2025.3869.
Warning: These citations may not always be 100% accurate.